Literature DB >> 26535123

Gender differences in symptoms in partial responders to proton pump inhibitors for gastro-oesophageal reflux disease.

N Vakil1, A Niklasson2, H Denison2, A Rydén2.   

Abstract

BACKGROUND: Gender differences may exist in the symptom experience of patients with gastro-oesophageal reflux disease (GERD) who have a partial response to proton pump inhibitors (PPIs).
OBJECTIVE: The purpose of this study was to analyse gender differences in partial responders to PPIs.
METHODS: Patients with GERD who responded partially to PPIs (n = 580; NCT00703534) completed the Reflux Symptom Questionnaire 7-day recall (RESQ-7) and the Gastrointestinal Symptom Rating Scale (GSRS). Anxiety and depression were evaluated using the Hospital Anxiety and Depression Scale.
RESULTS: Women had significantly higher RESQ-7 domain scores than men for Heartburn (frequency: 4.3 vs 3.9; intensity: 3.1 vs 2.8), Burping (frequency: 4.9 vs 4.4; intensity: 3.1 vs 2.8) and Hoarseness, cough and difficulty swallowing (frequency: 2.6 vs 2.2; intensity: 1.8 vs 1.5), and had higher GSRS domain discomfort scores than men for Abdominal pain (3.51 vs 3.23), Indigestion (3.80 vs 3.45) and Constipation (2.69 vs 2.17) (all p < 0.05). Anxiety and depression were significantly more prevalent in women than in men.
CONCLUSION: In this population of partial responders, women had more frequent/intense heartburn and extra-oesophageal symptoms and more discomfort from abdominal pain, indigestion and constipation than men. Comorbid anxiety and depression may contribute to the increased symptom burden in women.

Entities:  

Keywords:  Abdominal pain; extra-oesophageal symptoms; gastro-oesophageal reflux disease; gender differences; heartburn

Year:  2015        PMID: 26535123      PMCID: PMC4625745          DOI: 10.1177/2050640614558343

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  31 in total

Review 1.  Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis.

Authors:  Rebecca M Lovell; Alexander C Ford
Journal:  Am J Gastroenterol       Date:  2012-05-22       Impact factor: 10.864

Review 2.  Functional gastroduodenal disorders.

Authors:  Jan Tack; Nicholas J Talley; Michael Camilleri; Gerald Holtmann; Pinjin Hu; Juan-R Malagelada; Vincenzo Stanghellini
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

Review 3.  Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease.

Authors:  A Becher; H El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2011-07-20       Impact factor: 8.171

4.  Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.

Authors:  Frank Zerbib; Kafia Belhocine; Mireille Simon; Maylis Capdepont; François Mion; Stanislas Bruley des Varannes; Jean-Paul Galmiche
Journal:  Gut       Date:  2011-10-13       Impact factor: 23.059

5.  The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease.

Authors:  Ronnie Fass; Bruce D Naliboff; Shira S Fass; Nitzan Peleg; Christopher Wendel; Isaac B Malagon; Emeran A Mayer
Journal:  Gastroenterology       Date:  2007-12-07       Impact factor: 22.682

6.  [Burden of gastroesophageal reflux disease. Evidence from a recent methodological study in Spain].

Authors:  J M Piqué; K R Kulich; O Vegazoc; J Jiménez; J Zapardiel; J Carlsson; I Wiklund
Journal:  Gastroenterol Hepatol       Date:  2004-05       Impact factor: 2.102

7.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

Review 8.  Review article: gastro-oesophageal reflux disease and psychological comorbidity.

Authors:  I Mizyed; S S Fass; R Fass
Journal:  Aliment Pharmacol Ther       Date:  2008-11-08       Impact factor: 8.171

9.  Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients.

Authors:  P Bytzer; S Veldhuyzen van Zanten; H Mattsson; B Wernersson
Journal:  Aliment Pharmacol Ther       Date:  2012-08-01       Impact factor: 8.171

10.  Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study.

Authors:  D Jaspersen; M Kulig; J Labenz; A Leodolter; T Lind; W Meyer-Sabellek; M Vieth; S N Willich; D Lindner; M Stolte; P Malfertheiner
Journal:  Aliment Pharmacol Ther       Date:  2003-06-15       Impact factor: 8.171

View more
  1 in total

Review 1.  Sex and Gender Differences in Gastroesophageal Reflux Disease.

Authors:  Young Sun Kim; Nayoung Kim; Gwang Ha Kim
Journal:  J Neurogastroenterol Motil       Date:  2016-10-30       Impact factor: 4.924

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.